ImClone Systems Incorporated Names Cheryl Anderson Vice President, Regulatory Affairs

NEW YORK--(BUSINESS WIRE)--Jan. 3, 2006--ImClone Systems Incorporated (NASDAQ: IMCL) announced today that it has named Cheryl Anderson Vice President, Regulatory Affairs. In this role, Ms. Anderson will be responsible for developing and executing ImClone Systems’ strategy for addressing all regulatory issues on a global basis. Ms. Anderson will supervise the Regulatory Affairs functions of the Company related to clinical therapeutic development, compliance, safety, and manufacturing, and will report directly to Eric K. Rowinsky, M.D., Senior Vice President and Chief Medical Officer of ImClone Systems.

MORE ON THIS TOPIC